A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.
about
Comparison of Guidelines on Non-Muscle Invasive Bladder Cancer (EAU, CUA, AUA, NCCN, NICE)Diagnostics techniques in nonmuscle invasive bladder cancerApproaching the optimal transurethral resection of a bladder tumorEmerging endoscopic imaging technologies for bladder cancer detectionDiagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysisNarrow band imaging-assisted transurethral resection reduces the recurrence risk of non-muscle invasive bladder cancer: A systematic review and meta-analysisNatural biology and management of nonmuscle invasive bladder cancer.Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis.The impact of real-time 3d imaging by ultra-high speed optical coherence tomography in urothelial carcinoma.Recent advances in the diagnosis and treatment of bladder cancer.A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.Advantage of transurethral resection with narrow band imaging for non-muscle invasive bladder cancerA meta-analysis of narrow band imaging for the diagnosis and therapeutic outcome of non-muscle invasive bladder cancerCUA guidelines on the management of non-muscle invasive bladder cancer.Non-muscle-invasive bladder cancer: a vision for the future.A Comparison of the Progression and Recurrence Risk Index in Non-Muscle-Invasive Bladder Tumors Detected by Narrow-Band Imaging Versus White Light Cystoscopy, Based on the EORTC Scoring System.The role of narrow-band imaging in the management of non-muscle-invasive bladder cancer.The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.Technical solutions to improve the management of non-muscle-invasive transitional cell carcinoma: summary of a European Association of Urology Section for Uro-Technology (ESUT) and Section for Uro-Oncology (ESOU) expert meeting and current and futurRole of Narrow Band Imaging in Management of Urothelial Carcinoma.Image-Guided Transurethral Resection of Bladder Tumors - Current Practice and Future Outlooks.Tackling non-muscle invasive bladder cancer in the clinic.A More Thorough Transurethral Resection.[Narrow band imaging-assisted cystoscopy in bladder tumor follow-up: Can more tumors be identified?].Narrow band imaging for bladder cancer.[Non-muscle invasive bladder cancer : Current aspects of diagnostics, local therapy options and the update of the 2016 WHO classification].[Endourological imaging with narrow band imaging].[Therapy of low-grade nonmuscle-invasive bladder cancer].Decision Based on Narrow Band Imaging Cystoscopy without a Referential Normal Standard Rather Increases Unnecessary Biopsy in Detection of Recurrent Bladder Urothelial Carcinoma Early after Intravesical Instillation.Detection and recurrence rate of transurethral resection of bladder tumors by narrow-band imaging: Prospective, randomized comparison with white light cystoscopy.
P2860
Q26744756-02EBDA2B-2E03-43FB-A048-7950E9FBE337Q26775987-0BD59A30-9BAA-4E42-8CFA-8AACEE377EA9Q26829828-6B6DEBAC-C8B2-4A22-BC22-7E12A9054E97Q26853736-560ECE64-3F0B-47CC-8D9E-747CEA6958BBQ26859123-D85F8893-702E-4036-B16A-FB7312D0CF2AQ28073378-503E82D4-B62A-4780-A9A5-7851D8F02E0AQ33561637-DF8B76B8-062E-46FD-941B-D1B056F0B199Q34416939-5311C209-3E66-4D06-BD07-BA72A0A5F4D3Q34449687-EF8A3E79-12B6-40F3-BC50-D1549DE6D7D1Q34552725-AEBC68A5-D368-4D4C-B95E-DBB688AE25FCQ35732445-60528080-BD05-4A1C-BFB6-EF9F6FE404F9Q35871244-A534E78C-381F-4F52-91B2-87217B7FEE90Q36278598-B5E1B486-B4B4-435C-B3DB-AD28215DB4BCQ36326208-E03965BC-EF2A-4FDA-BF28-8EC1278E0FDBQ36378757-F7EFE849-4EB3-46E3-BE9E-F62D33BD17C4Q36655467-BFD2D0E8-DE59-4AE1-8A0A-F9EC38AE56FDQ38068581-ED970D33-7835-4843-AD81-EA35814DB981Q38156070-1825161D-F116-4000-B884-1B1C8676E24BQ38342245-A4B948C9-D180-4E8C-B1EC-3CEFBA97AA69Q38533132-58B99E64-5795-45EF-9786-6409B48FC7B9Q38639727-7458B11A-9BF2-4094-A466-4FB72CC4139DQ39209020-DC42B1ED-A86C-484C-902A-EEC7B59F44E9Q42327559-FE210259-FE5E-4CC0-83D2-6E8D27E47BD0Q50209898-A8737372-09E9-47A5-9297-202F722F9494Q50937418-5C47C96C-670E-4300-AC40-BFBCEAD79192Q53050660-7E8209BD-152C-4A6C-B0CF-782B7E3334ADQ53158037-E8176497-6527-432B-86A7-655D0F1C7E29Q53579420-C0B9B0F4-9FE2-49B9-B0FE-E7DE0C1CB85FQ55058236-85ED0ED5-2FA8-40D3-8425-B0DE7397886FQ55402423-1CA7D301-5BC2-49D4-B0F8-C1926A0F7BE2
P2860
A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non-muscle-invasive bladder cancer recurrence.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A randomized prospective trial ...... ive bladder cancer recurrence.
@en
A randomized prospective trial ...... ive bladder cancer recurrence.
@nl
type
label
A randomized prospective trial ...... ive bladder cancer recurrence.
@en
A randomized prospective trial ...... ive bladder cancer recurrence.
@nl
prefLabel
A randomized prospective trial ...... ive bladder cancer recurrence.
@en
A randomized prospective trial ...... ive bladder cancer recurrence.
@nl
P2093
P1433
P1476
A randomized prospective trial ...... ive bladder cancer recurrence.
@en
P2093
Angelo Naselli
Bruno Spina
Carlo Introini
Francesco Germinale
Franco Bertolotto
Luca Timossi
Paolo Puppo
Riccardo Pezzi
Vincenzo Fontana
P304
P356
10.1016/J.EURURO.2012.01.018
P407
P577
2012-01-20T00:00:00Z